Status:
COMPLETED
The Effectiveness of Aromatherapy in an Urban, Safety-Net Hospital on Pain
Lead Sponsor:
Parkland Health and Hospital System
Conditions:
Pain Management
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this project is to evaluate the effectiveness of aromatherapy on reducing pain in the acute care setting at Parkland Health and Hospital System. The target population for this study wil...
Detailed Description
This study will evaluate the impact of aromatherapy on the administration of opioid pain medication administration among the inpatient Surgical Services population. Patients from multiple units (burns...
Eligibility Criteria
Inclusion
- A) For the current study group:
- Inpatients, 18 years and older, admitted to a surgical service inpatient unit and who are experiencing pain and/or anxiety, and
- No history of chronic pain, respiratory problems, asthmas, allergies, or lost sense of smell, and
- Provide informed consent to participate in the study, and
- Complain of pain and anxiety in the 72 hours after surgery or intervention and requiring PANX.
- B) For the historical control group:
- • Patients from the same time in the previous year with the same inclusion and exclusion criteria.
Exclusion
- A) For the current study group:
- Patients with known allergies or sensitivities to aromatherapy products.
- Lack of interest in participating in or subsequent withdrawal from the research.
- Patients who are intubated, have died, or had serious disease complications will also be excluded from the study time period and previous year historical control group.
- Subject withdrawal from the Study
- Patients who develop allergic symptoms while the aromatherapy patch is applied.
- Patients who require intubation or critical interventions during their hospitalization.
- B) For the historical control group:
- • Anyone who does not meet the inclusion criteria
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2023
Estimated Enrollment :
184 Patients enrolled
Trial Details
Trial ID
NCT04840212
Start Date
March 1 2021
End Date
March 15 2023
Last Update
March 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Parkland Health and Hospital System
Dallas, Texas, United States, 75235